CN Patent

CN111978317A — 咪唑并吡啶类mnk1/mnk2激酶抑制剂及其制备方法和应用

Assigned to China Pharmaceutical University · Expires 2020-11-24 · 5y expired

What this patent protects

本发明提供了一种咪唑并吡啶类MNK1/MNK2激酶抑制剂及其制备方法和应用，具体地，本发明提供了一种式(I)所示的化合物：或其立体异构体、互变异构体或药学上可接受的盐。本发明的化合物可以用于制备治疗MNK活性或表达量相关的疾病或病症的药物组合物。

USPTO Abstract

本发明提供了一种咪唑并吡啶类MNK1/MNK2激酶抑制剂及其制备方法和应用，具体地，本发明提供了一种式(I)所示的化合物：或其立体异构体、互变异构体或药学上可接受的盐。本发明的化合物可以用于制备治疗MNK活性或表达量相关的疾病或病症的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN111978317A
Jurisdiction
CN
Classification
—
Expires
2020-11-24
Drug substance claim
No
Drug product claim
No
Assignee
China Pharmaceutical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.